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Abstract 
Objective: To determine the prevalence of cardiovascular disease (CVD) risk factors in current field-
based athletes. 
Design: Meta-analysis. 
Methods: This review was conducted and reported in accordance with PRISMA and pre-registered with 
PROSPERO. Articles were retrieved via online database search engines, with no date or language 
restriction. Studies investigating current field-based athletes (>18years) for CVD risk factors according 
to the European Society of Cardiology and American Heart Association were screened. Full texts were 











AXIS tool. Individual study estimates were assessed by random-effect meta-analyses to examine the 
overall effect. 
Results: This study was ascribed a 1b evidence level, according to the Oxford Centre for Evidence-
based Medicine. 41 studies were identified, including 5,546 athletes from four sports; American 
football; soccer; rugby and baseball (mean ages:18-28). Despite participation in sport, increased body 
mass was associated with increased total cholesterol, low-density lipoprotein, triglycerides, 
hypertension, systolic blood pressure, and decreased high-density lipoprotein. Linemen had increased 
prevalence of hypertension compared to non-athletes. Conflicting findings on fasting glucose were 
prevalent. There were inconsistencies in screening and reporting of CVD risk factors. Sport specific 
anthropometric demands were associated with elevated prevalence of CVD risk factors, most notably: 
elevated body mass; dyslipidemia; elevated systolic blood pressure and; glucose 
Conclusions: There are elevated levels of risk for CVD in some athletes, primarily football players. 
Lifestyle behaviours associated with elite athleticism, particularly football linemen potentially expose 
players to greater metabolic and CVD risk, which is not completely offset by sport participation.  
 
Keywords: Cardiovascular; athlete; risk-factors; evidence-based review; heart disease 
Introduction 
While clinical cardiovascular disease (CVD) is rare among young, highly active athletes, they are 
exposed to known risk factors such as increased body size, elevated blood pressure (BP) and 
abnormal lipoprotein profiles.1,2 Athletes represent a unique cohort of adults who engage in known 
healthy behaviours to maximise performance. However, certain behaviours are associated with CVD 
risk factors, particularly in sports where size is important, such as American football and rugby.1,2 In 
sports where body size is integral to successful participation, athletes often pursue extreme solutions 
to gain a competitive advantage that can jeopardise their long-term cardiovascular health. This 











playing time body mass index (BMI) above 30 kg.m2,3 and morphologic adaptations of an athlete’s 
heart.4  Despite American football players having a lower overall mortality risk, the NIOSH study 
revealed that linemen had a 52% greater risk of dying from CVD than the general population.5 
Increasing player size and sporadic deaths of active young retired professional athletes 6 warrants 
timely investigation into the cardiovascular health of current field-based athletes.  
Therefore, the purpose of this paper was to systematically review the evidence on the 
cardiovascular health and risk factors for CVD in current sportsmen and sportswomen, and to 
investigate the influence of other factors associated with CVD including, obesity, hypertension, 
dyslipidemia, insulin resistance and cardio-metabolic syndrome. 
 
Methods  
This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews 
and Meta-analysis (PRISMA) statement.7 (www.prisma-statement.org) and was registered with 
PROSPERO, a registry of systematic reviews. Registration is available 
at https://www.crd.york.ac.uk/prospero/; registration number: CRD42017077885.  
Articles were retrieved via online database search engines, including; CINAHL, EMBASE, 
Pubmed, and WOS. The reference lists of all reviews and meta-analysis related to the cardiovascular 
health and A systematic literature search was conducted using the online databases of CINAHL, 
EMBASE, Pubmed, and WOS from their inception to November 2019. No search restrictions were 
imposed. The search strategy key words, MeSH terms and combinations of these words included, 
CVD, cardiovascular health, blood pressure, lipids, cholesterol, cardio-metabolic syndrome, 
hypertension, glucose intolerance, body composition, BMI, body fat percentage, low-density 
lipoprotein, high-density lipoprotein, triglycerides, total cholesterol, sleep-disordered breathing, field-
based athlete, American football, baseball, field hockey, rugby, GAA and soccer. Studies include 
human subjects only. Studies were identified that could provide information on the prevalence of 











Association.2 All study designs were included. Participants were currently engaged in a field-based 
sport and over 18 years. The  electronic database search was supplemented by a manual search of the 
reference lists of all reviews and meta-analysis related to the cardiovascular health and articles 
meeting the eligibility criteria. The authors of studies that presented data incorporated with 
components from inclusion criteria were contacted for further information relevant to this review. 
The search methodology and process are described in Figure 1. The title and abstracts of the 
retrieved studies were independently screened in accordance with the pre-defined inclusion criteria. 
Following this, two reviewers independently assessed full texts. A third reviewer was available to 
make a final decision if consensus was not reached. Eligible articles were screened in a full text using 
Covidence (https://www.covidence.org/home) and the AXIS tool was used for critical appraisal.8 Data 
extraction from selected studies was conducted using STROBE guidelines (Appendix A).9  
A meta-analysis was deemed appropriate to examine the overall effect. Heterogeneity 
between studies was determined by the I2 statistic, 10 as an indicator of the proportion of total variation 
in estimates that is caused by heterogeneity. I2 values of 25%, 50% and 75% correspond to low, 
moderate and high degrees of heterogeneity. Sensitivity analysis was implemented where high levels 
of heterogeneity (I2 > 75%) were detected. 
Results 
The results from the literature search and selection of articles are summarised in Figure 1. Overall, the 
search retrieved 1,828 publications. A title screening for duplicates left 1,816 papers for abstract 
review. Review of abstracts left 233 papers for full text screening. Of 233 studies, 152 were excluded 
as study outcomes were not relevant to traditional cardiovascular health assessment, for example; 
electrocardiogram and/or echocardiogram. Thirty-two studies were excluded because participants 
included cohorts beyond inclusion criteria; data amalgamated with participants less than 18 years or 
athletes were retired. Three studies were removed due to incompatible study design. Authors of five 
studies were contacted for further information and data applicable to this study. Overall, 41 studies 










Of relevant studies, 28 were cross sectional, 6 descriptive, 2 observational, 2 prospective-
longitudinal, and 1 randomised control, pre- and post- test and retrospective study design. Thirty-nine 
studies included male participants and 2 included female participants. Thirty studies included 
American football athletes (29/41), 8 from soccer (8/41), 3 from rugby (3/41) and 1 from baseball 
(1/41). Of the 30 American football studies, 13 included professional football athletes and 17 included 
collegiate athletes. Athletes were compared with age-sex-BMI matched non-athletic individuals 
and/or cohorts from the Coronary Artery Risk Development in Young Adults CARDIA 11 and the 
National Health and Nutrition Examination Survey 2000 (NHANES).12 Analysis was carried out to 
compare risk factors based on playing position, race and the presence of cardio-metabolic syndrome 
(Appendix A). The primary aim of these studies was to assess the prevalence of CVD risk factors, 
dissimilarity in the prevalence and severity of risk factors based on race and playing position, and the 
role of body composition on players CVD risk factor profile. 
Body Composition:  
Thirty-three studies measured body composition, 30 of which assessed BMI. Football and rugby 
players had a greater mean BMI than comparators.13-20 Sub-group analysis of football players found 
that linemen position was associated with a significantly greater BMI than non-linemen.17,19,21-28 
Ninety percent of studies reported that linemen had BMI ≥30 kg.m2; many of which reported a BMI 
exceeding 32 kg.m2.21,22,24,27 Baseball players had a lower percentage of athletes with BMI ≥30 kg.m2 
compared to controls and football players (Appendix B).29 Soccer players had a similar mean BMI to 
controls.30,31  
 Rugby players had a significantly greater body fat percentage than race-walkers but lower 
than sedentary controls.13,14 Mixed findings were reported in football when compared to controls; two 
studies reported lower and one study reported a greater body fat percentage for players (Appendix 
B).32-34  Nine studies reported a greater body fat percentage for linemen compared to non-linemen 











25%.37 One study reported lower mean body fat percentage in female soccer players compared to 
controls.30 
 Fourteen studies included waist circumference as a measure of body composition. Baseball 
players had a significantly lower percentage of athletes with waist circumference ≥100cm compared 
to football players and controls.29 Three studies reported higher waist circumference values for 
football players than controls (Appendix B).16,17,38 All studies reported that linemen had a significantly 
greater waist circumference than non-linemen (Appendix B). 17,22,24,25,27,35,38 In collegiate football 
players, Division III players had a significantly lower waist circumference than players from division 
I and II.37 Five studies included waist-to-hip ratio as an outcome measure. A similar waist-to-hip ratio 
was reported for soccer players compared to sedentary controls (Appendix B).31 Baseball players had 
significantly lower percentage of athletes with waist to hip ratio >0.5 compared to footballers and 
controls.29 Three studies assessed waist to hip ratio in football players, all reporting a higher value for 
players compared to controls.16,17,38 
 All studies on football reported a greater prevalence of BMI >30kg.m2, WC >100cm, WHR 
>0.5 and BF% >25% compared to other athletes and controls. Sub-group analysis found elevated 
measures of body composition for linemen compared to non-linemen. Baseball and rugby had similar 
measures of body composition to controls, whereas, soccer athletes had lower body fat percentage 
than controls. 
Hypertension: 
Ten studies reported a prevalence of hypertension ranging from 13.8% to 53% across all field-based 
athletes. A higher prevalence of hypertension for football players,16,18,28,38 and baseball players was 
reported compared to controls.29 Rates of pre-hypertension were significantly greater for athletes 
compared to controls, except for one study that reported a lower prevalence (61.9% v 64.4%).18 
Linemen had higher rates of hypertension than non-linemen in all studies.25,28,38 Analysed by race, 












 In summary, the prevalence of hypertension and pre-hypertension was greater for baseball 
and football players compared to non-athlete controls. Linemen had a similar higher prevalence of 
hypertension and pre-hypertension compared to non-linemen. 
Blood Pressure: 
Most studies measuring BP were on a football cohort. Football players had higher BP than controls in 
four studies;17,18,20,34 although one study reported lower BP than BMI matched controls (Appendix 
C).33 When the influence of football playing position was analysed, higher BP for linemen compared 
to non-linemen was reported (Appendix C).17,19,22,23,25,27,28,32,35 Soccer players were found to have 
significantly higher systolic BP,40 and lower prevalence of optimal BP than controls (Appendix C).41 
In players where cardio-metabolic syndrome was present, resting systolic BP and diastolic BP was 
greater.42,43 Race was not associated with elevated BP amongst football players.16,19  
 In summary, the studies in our review predominately measured BP in American football and 
soccer athletes, who showed significant BP elevation compared to controls. BP increased with body 
mass.  
Lipid Profiles: 
Twenty-nine studies assessed measures of lipid profile. Soccer, football and rugby players had lower 
or equivalent measures of total cholesterol compared to controls (Appendix C).13-15,19,30,31,33,34,44,45 
HDL was measured in baseball and football. Baseball had a lower percentage of players with high 
HDL levels (>40mg.dl) compared to controls.14,15,29 Football players had similar HDL values as 
controls in four of six studies.17,32,33,46 
 Studies examining football found elevated LDL values comparable with controls.16,17,19,34 In 
contrast, rugby players,14,15 and male soccer players,31,45 had lower mean LDL values compared to 
control groups; 93.5mg.dl and 102.95mg.dl, respectively. Similar values for female soccer players and 











 Mixed findings were reported when mean triglyceride levels were measured in football; three 
studies reported lower values 19,34,38 and three reported higher values compared to control 
groups.17,32,33 Baseball players had lower prevalence of high triglycerides compared to controls and 
football players.29 In the presence of cardio-metabolic syndrome, athletes had significantly higher 
triglyceride values.42 
 Comparison of position of play in football showed that linemen position was reported with 
higher total cholesterol in 3 studies 19,22,35 and similar values in two studies compared to non-
linemen.16,17 Nine studies reported higher HDL values for non-linemen compared to linemen 
(Appendix C).17,19,22,23,25,27,32,35,38 Six studies reported higher values of elevated LDL17,19,22,23,25,35 and 
six reported higher triglyceride values for linemen compared to non-linemen.17,19,21,22,35,38 
 When race was analysed, black players had increased total cholesterol compared to white 
players but lower than Asian players (Appendix C).19,47 Black race was associated with higher HDL 
values than white and Asian players.16,19,47 
 In summary, athletes from baseball, soccer and rugby were found to have a more favourable 
lipid profile than football players and non-athlete controls. The studies in our review reported an 
inverse relationship with HDL and a direct relationship with total cholesterol, LDL and triglycerides 
as body mass increased. 
Glucose: 
Conflicting findings were found within and between sports. Significantly lower mean fasting glucose 
(FG) and lower prevalence of impaired FG for football athletes compared to controls were 
reported.16,17,33 Although, other studies reported higher FG levels for football players compared to 
controls (Appendix C).32,34 In the same sport, a higher percentage of players with FG ≥100mg.dl was 
reported compared to controls.33,38 Baseball players had a decreased prevalence of FG ≥100mg.dl 
compared to controls and football players.29 Rugby players had similar fasting glucose to controls.15 











linemen (Appendix C). 23,25,27,32,35 When cardio-metabolic syndrome was present, significantly higher 
FG was reported for football players.42,43 
 In summary, findings for FG for football and rugby players were inconsistent. As body mass 
for football players increased high FG levels were found.  
Cardio-metabolic Syndrome and Sleep-disordered Breathing: 
Prevalence of 19-22% for cardio-metabolic syndrome for football players was reported. 27,29,38,42 When 
football playing position was analysed,  studies reported a higher prevalence of cardio-metabolic 
syndrome in linemen compared to non-linemen.22,29,35,36,38,42 The most prevalent components of 
cardio-metabolic syndrome reported in athletes were elevated waist circumference/BMI, increased BP 
and low HDL values.35,37 When between sport comparison was made, baseball players were found to 
have a lower prevalence of cardio-metabolic syndrome compared to controls and football linemen, but 
higher prevalence than non-linemen.29 Two studies reported a prevalence of mild sleep-disordered 
breathing of 8% and 19%, respectively which was not influenced by playing position in football 
athletes.48  
In summary, cardio-metabolic syndrome was predominately assessed in football players. As 
body mass increased a greater prevalence of cardio-metabolic syndrome was reported. Linemen 
position was not found to influence the prevalence of sleep-disordered breathing.  
Critical Appraisal and Level of Evidence: 
This study was ascribed a 1b level of evidence, according to the criteria of the Oxford Centre for 
Evidence-based Medicine.49 Each study was attributed a level of evidence by measuring the reliability 
and quality of evidence for key outcomes across comparisons was evaluated according to the AXIS 
tool criteria.8 The AXIS tool identifies twenty domains to determine the quality of a study. Overall, 
studies in this review were of moderate quality with common issues in several domains. Studies did 
not justify sample size as they were generally pilot, cross-sectional or observational in nature. 











samples were to the true population, likely to be an elite population. Studies did generally not identify 
funding sources, although it is unlikely to influence outcomes where there was no intervention. Where 
studies were assigned ‘unsure’ was generally due to incomplete reporting and where authors did not 
respond to clarify information (Appendix D). 
Meta-analysis: 
Implementation of meta-analysis using random-effects indicated that the overall effect of engagement 
in elite sport across all participants for systolic BP, glucose and HDL was not homogenous (I2 – 98%, 
95% and 91%, respectively). Heterogeneity for FG remained high (I2 -79%) for soccer and rugby 
studies following the removal of American football athletes through sensitivity analysis. There was an 
insufficient availability of studies to implement this sensitivity analysis for HDL and systolic BP. 
Several studies that analysed triglyceride levels between athletes and controls found a significant 
mean decrease of -3.78mg.dl (95% CI: -12.21, -4.65, I2=62%) in athletes (Appendix E). Studies that 
analysed American football players based on playing position; linemen and non-linemen found a 
significant mean decrease in FG of 3.34mg.dl (95%CI: 0.62, 6.06, I2=60%), systolic BP of 6.02mmHg 
(95%CI: 4.41, 7.63, I2=31%) (Figure 2), LDL of 7.54mg.dl (95%CI: 3.10, 11.99, I2=1%) (Figure 3), 
and triglycerides of 19.12mg.dl (95%CI: 9.66, 28.57, I2=60%) in non-linemen (Appendix E). Greater 
HDL concentrations were found for non-linemen, with mean difference of -6.93mg.dl (95%CI: -8.78, 
-5.08, I2=15%) (Appendix E). 
Discussion 
In this review, studies predominately measured American football athletes, with limited studies from 
other field-based sports. Several elevated risk factors in active field-based athletes were identified, 
primarily in American football players, 16,33,36,37,42 with reduced prevalence in players from other 
sporting disciplines.13-15,29-31,40,41,44,45,47 Despite reduced risk in athletes from rugby, soccer and 
baseball, athletes with larger body mass, display higher prevalence of CVD risk factors, possibly 
reflecting the established relationship with increased BMI.1,2 However, this postulation is based on 











the cardio-protective benefits of exercise where elevated BMI is present; although beneficial, exercise 
does not eliminate risk of future cardiovascular events.50 It is apparent that CVD risk factors are 
present and there is a need for a greater amount of research. 
There is a predilection of cardiovascular related research on athletes to concentrate on 
American football athletes. American football is graded as a class 2B sport; moderate static and 
dynamic stress,51 and is a heterogenous group and can be dichotomised by playing position; linemen 
and non-linemen. There appears to be greater concern for linemen, given their size and the repetitive 
blunt trauma due to high impact collisions and tackling. Elite athletes often engage in extreme 
lifestyle behaviours to gain a competitive advantage. In sports, such as American football and rugby 
where size is pivotal, these behaviours can include, deliberate body mass gain, through use of high-
caloric diets.52 Although this is not generalisable to all field-based sports and indeed all athletes, the 
long-term cardiovascular implications of prolonged engagement in these behaviours of those who 
require a large body size has not been established. Furthermore, the use of non-steroidal anti-
inflammatory drugs, opioid-based analgesics and surreptitious use of performance-enhancing drugs 
remain incompletely understood in relation to cardiovascular health.3 A recent systematic review of 
the cardiovascular health of retired field-based athletes suggested the prevalence and severity of CVD 
risk factors in retired athletes is influenced by their playing time body mass and playing position. 53 
Body Composition: 
Epidemiological research has consistently reported increased risk of cardiovascular death 
with increased BMI in the general population.54 Players with playing-time BMI of ≥35kg.m2 have a 
significantly greater incidence of CVD mortality than the general population.3 Elevated BMI (≥ 30 
kg.m2) was more prevalent in football players,16-20,28 and particularly linemen. 17,19,21-28 Athletes 
engaged in contact collisions; linemen in NFL and props in rugby tend to have higher body mass. 
Position specific body mass increases has the potential to expose these players to cardiovascular 











increased lean muscle mass but rather body fat. Furthermore, football athletes reported a greater 
prevalence of waist circumference ≥100cm, body fat percentage ≥25% and waist to hip ratio ≥0.5.  
Eleven studies found a positive association between increasing BMI and body fat percentage 
for linemen and non-linemen and inter-divisional at collegiate level.13,16,17,22-25,27,34,35,48 Interestingly, 
four studies indicated that despite increasing body fat with increasing BMI, body fat percentage in 
athletes was lower than expected.13,17,25,55 Findings suggest that exercise, although beneficial may not 
prevent heavier players from developing CVD risk factors. Precision of body fat outcomes are 
dependent on the methods implemented, allowing for speculation on accuracy when comparing 
findings.56 Mean waist circumference for all football players and larger players (99.24cm and 
107.9cm, respectively) exceed proposed cut-off points.1 Furthermore, 14% of football players and 
71% of linemen with body fat percentage % ≥25% 16,27 and the 38% of football players and 95% of 
linemen with waist circumference ≥100 cm.29,38 It remains unknown if athletes with measures 
exceeding proposed cut-off points are exposed to the same CVD implications seen in the general 
population. 
Overeating is necessary for increasing body mass, potentially increasing the risk of elevated 
body fat and visceral fat which can negatively impact the metabolic health of the athlete.36 Due to the 
vast number of cofounding factors it is not possible to indicated that the presence of CVD risk is 
exclusively caused by excess weight. It is assumed that elite athletes are attuned to their overall well-
being. However, the demands of elite sports often cause additional stresses. Nattiv et al reported that 
collegiate athletes had a significantly higher proportion of maladaptive lifestyle behaviours, including 
overeating, steroid use, use of alcohol and drugs.57 Given the high level of alcohol and substance use 
reported in collegiate athletes, and elevated use in retired NFL players,58 it is not appropriate to 
eliminate these as a possible causes of cardiovascular mortality in this population. 
Blood Pressure: 
There is a strong relationship between elevated BP in early adulthood and CVD in later life;59 











hypertension and pre-hypertension for football players compared to other athletes and controls. A 
high prevalence of pre-hypertension; a recognised risk factor for CVD,1 was consistently reported, 
particularly for collegiate football players.18,32,33,42,60 An association between current NFL players and 
increased prevalence of hypertension (13.8%) compared to age-and-sex matched controls (5.5%) was 
identified.16 The direct comparison of football players with endurance-based athletes indicates that 
development of hypertension and increased BP is not a uniform response to all forms of high-intensity 
exercise (Appendix C).28 It is plausible that increased BP is a by-product of high-intensity strength-
based training and therefore, reversible during retirement.  
Reporting of higher mean systolic BP for football and soccer players compared to controls 
was common. Elevated systolic BP may be due to increased resting stroke volume and cardiac output 
associated with elite athleticism.51,59 It is possible that athletes’ body composition plays a role in 
elevated resting systolic BP, irrespective of playing position.18,25,26,35 However, linemen playing 
position was predominately associated with increased BP and hypertension.16,17,19,23,27,28,32,33,36,38 A 
multitude of factors may explain this; including, long term use of non-steroidal anti-inflammatory 
drugs, strength and resistance training, stimulant use, and pre-existing cardiovascular risk factors.3,4 
Findings from the meta-analysis indicate more favourable systolic BP for non-linemen (Figure 2), 
highlighting negative implications associated with position specific demands. Players of different 
races experience elevated measures of BP and higher rates of hypertension and pre-hypertension 
compared with age-and-race equivalent controls from the CARDIA study.16,26 The recent re-
classification of hypertension from140/90mmHg to 130/80mmHg  dramatically increases the number 
of athletes with elevated BP and hypertension.61 Although the pathophysiology of hypertension differs 
from the general population, long-term exposure may lead to similar negative effects on arterial 
function and increased risk of premature CV mortality.  
Lipid Profiles: 
Increased measures of body mass were found to be associated with an elevated prevalence of 










relationship with HDL.16,21,33,36 The Canadian Heart Health Surveys Research Group supports our 
finding that dyslipidemia primarily affects linemen, possibly due to increased body size.54 Athletes 
with optimal body fat percentages were reported with a more favourable lipid profile compared to 
other athletes,22,23,25,35 and controls, despite higher BMI.13,14 Controls were predominately matched for 
BMI; potentially underestimating the beneficial effects of exercise and justification for lack of 
significant differences.  
 The majority of studies found no differences in prevalence of elevated LDL between football 
players and controls.16,17,19 However, controls had significantly higher prevalence of LDL above 
recommended cut-off levels than athletes.2,33,36 Linemen have higher LDL values than non-linemen, 
with a mean value of 111.7mg.dl,17,19,22,23,25,35 suggesting although players are engaged in high-
intensity exercise, elevated body mass may counteract benefits of exercise on plasma LDL.21 The 
Forest plot for LDL (Figure 3) identified a common positive effect of non-linemen position on LDL 
levels, suggesting elite athletes competing at lower body masses have lower LDL levels. Despite 
similar total cholesterol values for linemen and non-linemen,16,17 non-linemen had greater mean HDL 
values (Appendix C).17,19,22,23,25,27,32,35,38 This supports the claim that increased BMI has an inverse 
relationship with HDL.2,54 Despite conflicting results concerning triglyceride values, there is a strong 
association between increased BMI and triglyceride levels.16,17,19,21,22,32,33,35,38 Large confidence 
intervals are observed for triglycerides between athletes and controls; however, there was a significant 
mean difference with athletes having lower values. Studies where athletes were found to have 
elevated triglyceride levels include football players and those with lower triglyceride levels than 
controls were predominately soccer players. 
Glucose: 
Findings on glucose are conflicting. It is unclear as to why non-linemen have similar or marginally 
lower mean FG values as linemen 23,25,27,32 and higher prevalence of players with FG ≥100mg.dl than 
controls, given their significantly lower BMI ( Appendix B; Appendix C).16 A possible explanation 











similarities in dietary lifestyles of players during playing career. The increased BMI and high-caloric 
diet in the cohort poses a risk for hyperglycemia leading to insulin resistance, an underappreciated 
factor in CVD development.1 
Cardio-metabolic syndrome: 
A major finding of this review was the lower mean HDL values and lower percentage with HDL 
≥40mg.dl in football players. 16,29,33,38 Buell and Mansell reported that elevated waist 
circumference/BMI, increased BP and low HDL values were the most prevalent components of 
cardio-metabolic syndrome.35,37 Standard metabolic dysfunctions which typically coincide with 
obesity cannot be presumed to be present in athletes with elevated BMI. However, this appears to not 
be the case from findings in this review. Football linemen predominately aged between 20-30 years, 
exhibit multiple metabolic dysfunctions compared to non-linemen and age-sex-matched 
controls.22,29,35,36,38,42 Persistent reporting of elevated waist circumference, body fat percentage and 
waist to hip ratio is significant given the role of obesity in development of cardio-metabolic syndrome 
and CVD. Thus, can engagement in sport offset the risk of the CV related health risks associated with 
elevated body mass? C-reactive protein (CrP) is a moderate predictor of cardiovascular health, 62 yet 
only two studies within this review analysed it. Given the association between high CrP, elevated 
BMI and elevated triglycerides,62 both evident in this review, further investigation is warranted. 
This review is predominated by American football athletes; therefore, it is important to mention the 
reported harmful behaviours associated, particularly the use of stimulants.63 Speculation of stimulant 
use among athletes has long persisted. A recent meta-analysis found that the global prevalence rate of 
anabolic-androgenic steroids (AAS) use in elite athletes was 13.4%. 64 There is a notable absence of 
research reporting the level of AAS use in athletes given their illegal status. Horn et al., indicated that 
9.1% of retired players self-reported using AAS during their career. 63 Growing evidence indicates 
negative effects of AAS on CVD risk factors. Studies have reported that AAS users have increased 
resting and exercise systolic BP; 65 negative alterations in lipid profiles; decreased HDL, increased 












This review is limited by several factors. Studies did not analyse the same cardiovascular measures, 
and incorporated multiple methods of investigation, most notably for body fat percentage. Most 
studies included were cross sectional, limiting ability to infer causality, therefore, findings should be 
viewed as hypothesis generating only. Studies predominately included male American football 
athletes, limiting generalisability. Therefore, caution is needed when applying findings to other 
current field-based athletes and female athletes. There is a lack of longitudinal and follow-up research 
tracking current athlete’s cardiovascular health into retirement. Finally, there are several possible co-
founding measures that were not assessed, including cardiovascular health and body composition 
prior to playing, years playing, diet, alcohol use, AAS use, socioeconomic status, education, genetics 
and/or use of medications. 
Conclusion: 
Many current athletes exhibit multiple risks for future CVD, confirming a need for further research. 
Elevated levels of risk have been clearly identified in active athletes, primarily football players, with 
reduced prevalence in players from other sporting disciplines. Lifestyle behaviours associated with 
elite athleticism, particularly football linemen, potentially expose players to an increased metabolic 
and CVD risk. Athletes at increased CVD risk have elevated body mass and/or BMI, which is similar 
to research findings in the general population. Attention to larger athletes is needed for preparing 
them for retirement in terms of education on dietary habits and remaining engaged in physical 
activity.   
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Figure 1: PRISMA  flow diagram depicts the flow of information through each stage of   the 
screening process of articles retrieved from online databases and the selection of eligible articles.  
Figure  2: Forest plot examining the overall effect on systolic BP between football players based on 
playing position, categorised as linemen and non-linemen.  
Figure 3: Forest plot examining the overall effect on LDL between football players based on playing 
position, categorised as linemen and non-linemen. 
Figure 4:  Forest plot examining the overall effect on triglycerides between athletes and non-athlete 
controls. 
Figure 5: Forest plot examining the overall effect on Glucose between football players based on 
playing position, categorised as linemen and non-linemen. 
Figure 6: Forest plot examining the overall effect on HDL between football players based on playing 
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Abbreviations: LM - linemen; NLM - non-linemen; BMI- body mass index; WC- waist circumference; WHR- 
waist-hip-ratio; BF% -  body fat percentage; HT- hypertension; SBP- systolic blood pressure; DBP- diastolic blood 
pressure; MAP- mean arterial pressure; HL- hyperlipidemia; HDL- high-density lipoprotein; LDL- low- density 
lipoprotein; LDL-P- low-density lipoprotein particle number; TG-triglycerides; TC- total cholesterol; VLDL- very 
low density lipoprotein; APO- apolipoprotein; ALT- alanine aminotransferase; CMS- cardio-metabolic syndrome; 
DM - diabetes mellitus; IFG- impaired fasting glucose; IR: insulin resistance; hsCRP- high sensitive C reactive 
protein; FA- fatty acid; CAC- carotid artery calcium; CAP- carotid artery plaque; ASCVD - atherosclerotic 
intercollegiate 
football athletes.  
 To collect pre-
season data of 
physical 
characteristics of 





TG, TC, IFG 
9.5% LM had HT, 42.9 % low 








 To determine if 
Omega-3 
essential fatty 
acids improve CV 
lipid risk factors. 
















TG (98.72) and VLDL (21.59) 
below desired cut-off points. 
HDL (44.91mg/dl) was above 
desired min values (≥ 40mg/dl). 
VLDL-3 was found to be 




























Elevated BP common black and 
white players (78% v 63%, 
p=0.34). Black players 
significantly better lipid profiles, 
body composition, and 






 To determine if 
CMS in football 























Prevalence of CMS was 33%. 
Elevated WC, HDL and elevated 
BP were present together in 
73% of players. Players had 
increased oxidative stress (F2-



















 To compare 
their profiles to 
professional, 
NCAA DI, II and 















SBP, DBP SBP was significantly and 
positively correlated (0.270) 
with BM. 23.5% of players had 
HT, 54% were pre HT, and only 








 To determine if 
playing football 





health profile.  
Preseason 
period for the 
Danish 
women’s 











BMI was lower in athletes (21.7 
v 24.0, p=0.035). no difference 
between groups in SBP or DBP 
(118 v 115 mmHg and 68 v 72 
mmHg respectively). 
Haemoglobin was 4% higher in 
athletes. TC, LDL and TG levels 
were not different between 
groups, whereas athletes had 










cardiovascular disease; IMT- Intima-media thickness; RCA- right coronary artery NFL- National Football League; 













Table 1: Body composition measures 
Author BMI kg.m2 BF% WC/NC WHR 
Tucker et al., 
2009 
NFL v CARDIA: 31.4 v 
25.9*** 
Mean: 16.1%.  
Offensive LM - 25.8; 
Defensive LM - 20.8  
NFL v CARDIA: 97 (97-98) v 86 
(86-87) *** 
NFL v CARDIA: 0.88 v 
0.85*** 
 
Selden et al., 
2009 
NFL > NHANES ***  WC ≥ 100cm:  
Team v Nhanes:38% (26) v 
26% 
LM v Nhanes: 95% (18) v 
26%, *** 
NLM v Nhanes: 16% (8) v 26% 
LM v NLM: 95% (18) v 16% (8) 
*** 
WHR >0.5 
Team v Nhanes:52% (36) v 
55% 
LM V Nhanes:95% (18) v 
55%, *** 
NLM v Nhanes:36% (18) v 
55%* 




Mean: 29.93 ± 4.32 All: 17.29 ± 7.37 
Group A (OLM, DLM) -25.62 
±7.37 
Group B (WR, DB)- 11.73 ± 
3.68 
Group C (TE, LB QB, K)- 14.42 
± 3.77 




et al., 2010 
 LM v Skill v Controls: 24.9 ± 
4.3 v 11.7 ± 1.8* v 26.8 ± 
13.4* 
  
Garry et al., 
2001 
Skilled; BMI <28 =69%, 
BMI 28-32 =31%, BMI >32= 
0%  
DE/LB/TE; BMI <28= 10%, 
BMI 28-32 =57%, BMI >32 
=33%  
LM; 100% LM had BMI >32 
   
Mansell et al., 
2011 
LM v NLM: 35.6 (3.5) v 
26.4 (2.4) *** 
LM v NLM: 26.4 (4.5) v 11.2 
(3.5) *** 
LM v NLM: 108.0 (9.1) v 82.9 
(3.8) *** 
 
Steffes et al., 
2013 











Big v Athletic v Skilled: 
32.9 ± 2.7 v 27.9 ± 2.5 v 
25.8 ± 1.9 
Big v Athletic v Skilled: 22.9 ± 
4.0 v 14.7 ± 4.5 v 10.1 ± 3.6 
Big v Athletic v Skilled: 100.6 
± 6.3 v 87.9 ± 5.5 v 81.3 ± 3.4  
Allen et al., 
2010 
IL v AO v CARDIA: 38 v 29.5 
v 25.9. 
IL > AO and CARDIA*; AO > 
CARDIA * 
IL v AO v CARDIA: 25.2 (24.4-
26) v 13.4 (12.9-14) v NA 
IL v AO v CARDIA:  116 (114-
118) v 92 (91-93) v 86 (86-87)  
IL > AO + CARDIA*; AO > 
CARDIA *  
IL v AO v CARDIA:  0.92 
(0.91-0.93) v 0.87 (0.86-
0.88) v 0.85 (0.84-0.85).  
IL > AO and CARDIA*; AO > 
CARDIA * 
Berge et al., 
2013 
Soccer v Controls: 23.7 
(1.1) v 23.2 (0.9) * 
   
Buell et al., 
2008 
 DI v DII v DIII: 26.2 ± 2.48 v 
28.3 ± 2.80 v 25.5 ± 3.92** 
DI + DIII >DII*** 
DI v DII v DIII: 111.8 ± 8.32 v 
115.3 ± 11.03 v 104.7 ± 
9.46*** 
DI + DII > DIII *** 
 
Haskins et al., 
2011 
Football v Controls: 35 v 
34.9 
Football Players v 





LM v NLM:37.6 v 29.1*** 
Mean: 17.5 
LM v NLM: 24.2(22.4-25.8) v 
13 (11.9-14) *** 
  
Arsic et al., 
2011 
Soccerl v Sedentary; 22.42 
± 1.33 v 22.10 ± 1.43 
Football v Sedentary: 19.92 ± 
3.25 v 25.38 ± 4.20* 
  
Brites et al., 
2004 
Soccer v Controls: 22.9 ± 
0.2 v 24.1 ± 0.9 
  Soccer v Controls: 0.81 ± 
0.01 v 0.81 ± 0.01 
Berge et al., 
2010 
Mean: 23.7 kg.m2    
Crouse et al., 
2016 
Mean: 28.7 ± 5.0 Mean: 16.5± 9.7   
Dobrosielski 
et al., 2016 
High Risk v Low Risk:33 ± 
5.4 v 27.6 ± 3.6*** 
 NC: High Risk v Low Risk: 44.6 




Skill v Big: 26.9 ± 2.5 v 32.6 
± 2.9*** 
Skill v Big: 12.6 ± 4.8 v 22 ± 
4.1*** 





 Football v Controls: 29.2 ± 7.9 
v 23.2 ± 7.0* 
  
Haluzik et al, 
1999 
Rugby v Race walkers:  
26.7 ± 1.85 v 20.7 ± 1.88* 
Rugby v Race walkers: 














BMI ≥ 30: 
Baseball v NHANES:7 (5%) 
v 67 (21%) ***  
Baseball v Football: 7 (5%) 
v 35 (51%) *** 
Baseball v LM: 7 (5%) v 19 
(100%) *** 
Baseball v NLM: 7 (5%) v 
16 (32%) *** 
 
 WC > 100cm 
Baseball v NHANES: 11 (7%) v 
85 (26%) *** 
Baseball v Football: 11 (7%) v 
26 (38%) *** 
Baseball v LM: 11 (7%) v 18 
(95%) *** 
Baseball v NLM: 11 (7%) v 8 
(16%) 
WHR > 0.5 
Baseball v NHANES: 37 
(23%) v 176 (55%) *** 
Baseball v Football: 37 
(24%) v 36 (52%) ***  
Baseball v LM: 37 (24%) v 18 
(95%) *** 




Football v Non-football: 
28.4 ± 4.3 v 23.8 ± 2.6, *** 
   
Hurst et al., 
2012 
Mean: 32 ± 5  
White Players v White 
Controls:  32 ± 4 v 29 ± 5 
*** 
Black Players v Black 
Controls: 31 ± 5 v 29 ± 
7*** 
NLM v LM: 29 ± 3 v 35 ± 
5*** 
   
Evelson et al., 
2002 
Rugby v Controls: 26.6 ± 
2.2 v 25.1 ± 2.2 
   
Kim et al., 
2015 
ASF v Controls: 30 ± 4.3 v 
24 ± 4*** 
   
Maso et al., 
2002 
Sportsmen v Controls: 27.4 
(3.1) v 23.5 (3.9) *** 
Sportsmen v Controls: 15.5 
(3.1) v 17 
 
  
Oliver et al., 
2015 
Mean: 26.9 ± 4.2    
Rice et al., 
2020 
Mean: 32.4 ± 4 
LM v NLM: 37.3 ± 2.v 30 ± 
3*** 
Mean: 17.9 ± 6.6 
LM v NLM: 24.7 ±3.3 v 14.3 ± 
4.9*** 
WC: Mean: 101 ± 14 
LM v NLM: 116 v 94*** 
NC: Mean: 44.5 ± 3.3 











Abbreviations: LM - linemen; NLM - non-linemen; AO – all others; OLM- offensive linemen; DML- defensive 
linemen; DE- defensive ends; LB- line-backers; RB- running backs; TE- tight ends; WR- wide receivers; K- kickers 
BMI- body mass index; WC- waist circumference; WHR- waist-hip-ratio; BF% -  body fat percentage; NFL- 
National Football League; NCAA - National Collegiate Athletic Association; ASF – American style football; CMS - 





Tucker et al., 
2015 
LM v DE/LB/RB/TE v 
QB/K/WR: 37 v 31 v 27*** 
   
Wilkerson et 
al., 2010 
Mean: 29.09 ± 4.54 
MS-Negative v MS-
Positive: 28.40 ± 3.97 v 
31.98 ± 5.76 
Mean: 15.38 ± 7.02 
MS-Negative v MS-Positive: 
14.39 ± 6.25 v 19.50 ± 8.76 
Mean: 90.55 ± 10.84 
MS-Negative v MS-Positive: 
88.63 ± 9.87 v 98.53 ± 11.43, 
p =0.004.  
 
Weiner et al., 
2013 
ASF v Controls: 27.6 ± 3.3 v 
24.4. ± 1.9 
LM v NLM:  28.7 ± 3.4 v 
26.2 ± 2.7 
   
Wright et al., 
2017 
LM v NLM: 33.9 v 26.6, p 
<0.001 
All v OLM v DLM: 33.8 v 
37.8 v 35.7 
All v OLM v DLM: 29.9 v 25.8 
v 20.8 
LM with BF% > 25% = 71.4% 
All v OLM v DLM: 102 v 117 v 
107 
 
All v OLM v DLM: 0.90 v 
0.92 v 0.89 
 
Powers et al., 
2015 
MS negative v MS positive: 
31.20 ± 3.01 v 34.72 ± 
2.50*** 
 MS negative v MS positive: 


















TC (mg.dl) HDL(mg.dl) LDL (mg.dl) TG (mg.dl) 
Tucker et 
al., 2009 
NFL v CARDIA:  
SBP: 127 v 112 *** 
DBP: 75 v 72 *** 
NFL v CARDIA: 
179 v 181 
 
NFL v CARDIA: 
48 v 49 
 
NFL v CARDIA: 
112 v 113 
NFL v CARDIA: 




SBP:126.7  ± 12.49, 
DBP- 70.24  ± 8.55 
 16.87 ± 25.78 39.36 ± 8.97 106.08 ± 23.9  82.56 ± 46.34 
Dobrosielski 
et al., 2010 
LM v Skill v Controls:   
SBP: 134 ± 12.0 * v 121 
± 5.0 v 123 ± 10 
DBP: 79 ± 6 v 73 ± 7 v 
77 ± 6 
 LM v Skill v 
Controls:  
HDL: 38*± 8 v 
49 ± 10 v 43 ± 
11 
 LM v Skill v 
Controls:  
TG:  111 ± 50 v 
129 * ± 72 v 75 
± 36 
Garry et al., 
2001 












BMI < 28 













LM v NLM:  
SBP: 109.2 (10.1) v 
106.1 (9.0) 
DBP: 64.6 (8.5) v 63.6 
(5.5) 
LM v NLM 
(mmol): 3.86 
(0.54) v 3.65 
(0.70) 
LM v NLM 
(mmol): 0.93 
(0.22) v 1.12 
(0.28) * 
LM v NLM 
(mmol): 2.53 
(0.49) v 2.05 
(0.41) ** 
LM v NLM 
(mmol): 1.05 




SBP: 122.4 ± 8.3; DBP: 
79.4 ± 5.6 
Big v Athletic v Skilled:  
SBP: 127.1 ± 9.0 v 
121.9 ± 8.3 v 118.8 ± 
5.4 
168.2 ± 28.1 
Big v Athletic v 
Skilled:  
172.6 ± 27.7 v 
170.4 ± 30.8 v 
161.4 ± 24.6 
46.0 ± 13.1 
Big v Athletic v 
Skilled:  
38.4 ± 12.1 v 
47 ± 13 v 51.3 
± 11.2 
106.2 ± 23.3 
Big v Athletic v 
Skilled:  
108 ± 26.6 v 
106.9 ± 23.8 v 
102.8 ± 18.5 
103.2 ± 57.0; 
Big v Athletic v 
Skilled:  
130.9 ± 71.2 v 
103 ± 51.1 v 











DBP: 81.2 ± 6.5 v 79.3 
± 5.5 v 78 ± 4 
Allen et al., 
2010 




182) v 181 
(179-182) 
IL v AO v 
CARDIA: 
43 (41-45) v 49 
(48-51) v 49 
(48-50).   
IL significantly 
< AO and 
CARDIA. 
IL v AO v 
CARDIA: 




IL v AO v 
CARDIA: 
121 (107-135) 
v 89 (83-94) v 
95 (91-99) 
IL significantly 
> AO and 
CARDIA * 
Berge et al., 
2013 
Football v Controls:   
SBP: 144.1 (7.5) v 114 
.2 (3.8)  
DBP: 76.9 (9.0) v 68.7 
(6.4) 
    
Haskins et 
al., 2011 
Football v Controls:  
SBP: 135.6 (13.3) v 
148.1 (13.8) ** 














90.9 (27.1) v 
116.3 (37.3) * 
Football v 
Controls:  




et al., 2012 
Mean: 127/77 
LM v NLM:   
SBP: 131 (128-133) v 
125 (122-127) ** 
DBP: 79 (77-81) v 75 
(73-77) ** 
Mean: 184 




LM v NLM: 46 
(42-50) v 50 
(48-52) ** 
Mean: 116 




LM v NLM:93 












et al., 2014 
 Soccer v 
Inactive: 179.3 
± 10.7 v 201.2 
± 10.5 ** 
Soccer v 
Inactive: 47.4 ± 
4.1 v 44.2 ± 6.6 
Soccer v 
Inactive: 110.9 
± 8.9 v 136.7 ± 
11.3 ** 
Soccer v 
Inactive: 78.3 ± 
6.7 v 177.6 ± 
18.6 ** 
Brites et al., 
2004 
 Soccer v 
Controls: 
















SBP: 126 ± 10 
DBP: 73 ± 9 
    
Feairheller 
et al., 2016 
Football v Controls:  
SBP: 128.2 ± 6.4 v 
122.4 ± 6.8 * 
DBP: 74.8 ± 4.1 v 73.9 
± 6.3  
Football v 
Controls: 136.6 



















 Rugby v Race 
Walkers 
(mmol): 4.04 ± 
0.5 v 3.95 ± 
0.79 
  Rugby v Race 
Walkers 
(mmol): 1.39 ± 




Football v Non-football 
SBP: 126.4 ± 11 v 122.5 
± 9.8 *** 
DBP: 75.3 ± 9.9 v 72.3 
± 9 *** 
Mean: 189 ± 
46 
NLM v LM: 183 
± 39 v 197 ± 54 
Mean: 53 ± 15  
NLM v LM: 59 
± 13 v 47 ± 15 
** 
Mean: 110 ± 
41 
NLM v LM:  
107 ± 38 v 114 
± 46 
Mean: 138 ± 
112 
NLM v LM: 86 




Mean:  SBP:123 ± 13; 
DBP: 75 ± 10  
NLM v LM:  
SBP: 118 ± 9 v 130 ± 14 
*** 
DBP: 74 ± 9 v 77 ± 10 
LM V NLM:  
197 v 183 
LM V NLM: 
47 v 59** 
LM V NLM: 
114 v 107 
LM V NLM: 












 Rugby v 
Controls: 175 v 
180 
Rugby v 
Controls: 60 v 
50 * 
Rugby v 
Controls: 90 v 
100 
Rugby v 
Controls: 70 v 
80 
Kim et al., 
2015 
ASF v Controls:  
SBP: 123 ± 9 v 118 ± 
13; DBP: 71 ± 9 v 72 ± 
11 
    
Kirwan et 
al., 2012 
 Mean: 164 ± 
88.3 
Mean: 68 ± 
16.2 




Maso et al., 
2002 
 Sportsmen v 
Controls: (mM) 
25 (0.76) v 
4.85 (0.87) ** 
Sportsmen v 
Controls: (mM) 
1.10 (0.22) v 
1.23 (0.28) * 
Sportsmen v 
Controls: (mM) 




0.80 (0.40) v 
1.02 (0.32) * 
Rice et al., 
2010 
Mean: SBP: 129 ± 11; 
DBP: 77 ± 8 
LM v NLM:  
SBP: 131 v 128, p 
=0.12; DBP: 79 v 75 ** 
 Mean: 47 ± 12 
LM v NLM: 43 
± 11 v 49 ± 12 
** 
Mean:  111 ± 
28 
LM v NLM: 116 




Group 1: Black v 
White:  
SBP: 126 (120, 135) v 
126 (120, 134) 
DBP: 76 (70, 82) v 76 
(72, 80)  
Group 2: Black v 
White:  
SBP: 122 (116, 128) v 
122 (116, 128) 
DBP: 72 (67, 78) v 71 
(68, 76) 











Group 3: Black v 
White:  
SBP: 122 (114, 129) v 
122 (115, 128) 




Mean: SBP: 129.65 ± 
6.21; DBP: 82 ± 5.50 
MS-Negative v MS-
Positive:  
SBP: 128.66 ± 5.59 v 
133.75 ± 7.20 ** 
DBP: 81.54 ± 5.20 v 
83.92 ± 6.47 
 Mean: 48.92 ± 
15.03 
MS-Negative v 
MS-Positive:   
51.52 ± 13.39 v 






163.88 ± 36.19 






91.42 ± 34.34 v 




ASF v Controls: 
SBP: 116 ± 8 v 114 ± 9; 
DBP: 64 ± 8 v 60 ± 9 
LM v NLM:  
SBP: 119 ± 8 v 113 ± 8 
*; DBP: 66 ± 8 v 62 ± 9 
* 
    
Wilson et 
al., 2012 
 West-Asian v 
Black-African 
(mmol):   
4.4 ± 0.8 v 4.18 
± 0.8 *  
West-Asian v 
Black-
African(mmol):   
1.3 ± 0.2 v 1.4 
± 0.2 ** 
West-Asian v 
Black-African 
(mmol):   





0.97 ± 0.8 v 













OLM v DLM 
SBP: 130.6 v 132 v 127; 
DBP: 76.2 v 79 v 75 
LM v NLM:  
SBP: 130.6 v 124.1 **; 
DBP: 76.2 v 74.2 
All v OLM v 
DLM: 
169.5 v 179 v 
185 
 
All v OLM v 
DLM: 
39.9 v 43 v 47 
 
All v OLM v 
DLM: 
116.1 v 115 v 
116 
 
All v OLM v 
DLM: 
93.9 v 119 v 
111 
 
Yates et al., 
2009 
SBP: 125.6; DBP: 74.7 
LM v NLM:  
SBP: 130.6 v 124.1 **; 
DBP: 76.2 v 74.2 
 Mean: 44.91 
 
 Mean: 98.72 
Powers et 
al., 2015 
MS negative v MS 
positive:  
SBP: 133.6 ± 8.8 v 
135.1 ± 7.3 
DBP: 69.1 ± 5.6 v 71.7 
± 7.6 
 MS negative v 
MS positive:  
45 ± 10 v 35.8 
± 8.42 ** 
 
 MS negative v 
MS positive:  
66.7 ± 77.8 v 





    
Wegmann 
et al., 2016 
SBP: 138 ± 15; DBP: 88 
± 8 
    
Arsic et al., 
2011 
 Football v 
Sedentary 
(mmol): 
TC: 3.94 ± 0.60 
v 4.35 ± 0.67 
  Football v 
Sedentary 
(mmol): 
TG: 0.58 ± 0.20 
v 0.82 ± 0.29 
Randers et 
al, 2013 
 Elite football V 
Untrained: 
(mM): 4.5 ± 0.9 
v 4.43 ± 4 
Elite football V 
Untrained: 
(mM): 1.8 ± 0.3 
v 1.5 ± 0.4 * 
Elite football V 
Untrained: 
(mM): 2.4 ± 0.7 
v 2.5 ± 0.7 
Elite football v 
Untrained: 
(mM): 0.82 ± 
0.1 v 0.99 ± 0.4 
Abbreviations: LM - linemen; NLM - non-linemen; AO – all others; HT- hypertension; SBP- systolic blood 
pressure; DBP- diastolic blood pressure; MAP- mean arterial pressure; HDL- high-density lipoprotein; LDL- low- 











fasting glucose; IFG- impaired fasting glucose; IR: insulin resistance; NFL- National Football League; NCAA- 
National Collegiate Athletic Association; ASF – American style football; CMS - cardio-metabolic syndrome, *-















Table 3: Critical appraisal of studies using AXIS 
(1 of 3) 
Ahrensfield 


































et al., 2010 
Dobrosielski 
et al., 2016 
Introduction   
Were the aims/objectives of the study 
clear? 
No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Methods   
Was the study design appropriate for 
the stated aim(s)? 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Was the sample size justified? No No No No No No No No No No No No No No 
Was the target reference population 
clearly defined? 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Was the sample frame taken from an 
appropriate population base so it 
closely represented the 
target/reference population under 
investigation? 
Unsure Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Was the selection process likely to 
select subjects/participants that were 
representative of the target 
target/reference population under 
investigation? 
Unsure Unsure Yes Unsure Unsure Unsure Unsure Unsure Unsure No No Yes Unsure Unsure 
Were measures undertaken to address 
and categorise non-responders? 
No Unsure No No No Unsure No No No No No No No No 
Were the risk factor and outcome 
variables measured appropriate to the 
aims of the study? 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Were the risk factor and outcome 
variables measured correctly using 
instruments/measurements that had 
been trialled, piloted or published 
previously? 
Unsure Yes Yes Yes Unsure Yes Yes Yes Yes Yes Yes Yes Unsure Yes 
Is it clear what was used to determine 
statistical significance and/or percision 
estimates? (e.g. Values , CI's) 











Were the methods (including statistical 
methods) sufficiently desribed to 
enable them to be repeated? 
Yes Yes Yes Yes Unsure Yes Yes Yes Yes Yes Yes Yes No Yes 
Results   
Were the basic data adequately 
described? 
No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Does the response rate raise concern 
about non-response bias? 
No No Unsure No No No No No No No No No Unsure No 
If appropriate, was information about 
non-responders described? 
No No No No No No No No No No No Unsure No No 
Were the results internally consistent? Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Were the results for the analyses 
described in methods, presented? 
Unsure Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes 
Discussion  
Were the authors' discussions and 
conclusions justified by the results? 
Unsure No Yes Yes Unsure Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Were the limitations of the study 
discussed? 
No Yes Yes Yes No Yes Yes No Yes No No Yes Yes Yes 
Other   
Were there any funding sources or 
conflicts of interest that may affect the 
authors' interpretation of the results? 
Unsure Yes No Unsure Unsure Unsure No Unsure Unsure Unsure No Unsure Unsure Unsure 
Was ethical approval or consent of 
participants attained? 





















































































Introduction   
Were the 
aims/objectives of 
the study clear? 
Yes No Yes Yes Yes No Yes No No Yes Yes Yes No No 
Methods   
Was the study 
design appropriate 
for the stated 
aim(s)? 
Yes Yes Yes Yes Yes No No Yes 
Ye
s 
Yes Yes Yes Yes 
Unsu
re 
Was the sample 
size justified? 
No No No No No No No Yes No No No No No No 




Yes Yes Yes Yes Yes Yes Yes Yes 
Ye
s 
Yes Yes Yes Yes Yes 
Was the sample 
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Yes Yes Yes Yes Yes Yes Yes Yes 
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Yes Yes Yes Yes Yes Yes Yes Yes 
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Yes Yes Yes Yes 
Unsu
re 











Yes Yes Yes Yes No Yes Yes Yes 
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Yes Yes Yes Yes 
Unsu
re 
Is it clear what was 





Values , CI's) 
Yes Yes Yes Yes Yes Yes Yes Yes 
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s 
Yes Yes Yes Yes 
Unsu
re 





Yes Yes Yes Yes Yes No Yes Yes 
Ye
s 











desribed to enable 
them to be 
repeated? 
Results   
Were the basic 
data adequately 
described? 
Yes Yes Yes Yes Yes Yes Yes Yes 
Ye
s 
Yes Yes Yes Yes Yes 
Does the response 
rate raise concern 
about non-
response bias? 
No No No No No No No No No Yes No No No 
Unsu
re 




No No No No No No No 
Unsur
e 
No No No No No 
Unsu
re 
Were the results 
internally 
consistent? 
Yes Yes Yes Yes Yes Yes Yes Yes 
Ye
s 
Yes Yes Yes Yes 
Unsu
re 
Were the results 




Yes Yes Yes Yes Yes No Yes Yes 
Ye
s 
Yes Yes Yes Yes No 
Discussion   
Were the authors' 
discussions and 
conclusions 
justified by the 
results? 
Yes Yes Yes Yes Yes Yes Yes Yes 
Ye
s 




limitations of the 
study discussed? 
No Yes Yes No Yes Yes Yes Yes 
Ye
s 
Yes Yes No No No 
Other   
Were there any 
funding sources or 
conflicts of interest 
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Was the study design 
appropriate for the 
stated aim(s)? 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Was the sample size 
justified? 
No No No No No Yes No No No No No No No 
Was the target 
reference population 
clearly defined? 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Was the sample 
frame taken from an 
appropriate 





Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Was the selection 
























No No No No Yes No No No No No No No 
Were the risk factor 
and outcome 
variables measured 
appropriate to the 
aims of the study? 
Unsu
re 
















ments that had been 




Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Is it clear what was 




Values , CI's) 
Unsu
re 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Unsu
re 
Were the methods 
(including statistical 
methods) sufficiently 
desribed to enable 
them to be repeated? 




Were the basic data 
adequately 
described? 
No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Does the response 





No No No No No No No No No No No No 






No No No No Yes No No No No No No No 




Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Were the results for 
the analyses 
described in methods, 
presented? 












Were the authors' 
discussions and 
conclusions justified 
by the results? 
Unsu
re 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Were the limitations 
of the study 
discussed? 
No No Yes Yes Yes Yes Yes Yes Yes No No Yes Yes 
Other  
Were there any 
funding sources or 
conflicts of interest 
that may affect the 
authors' 




No No No No No No No No Unsure No No 
Unsu
re 
Was ethical approval 













































Figure 4: Forest Plot of Triglyceride levels for Athletes v Controls 
Figure 5: Forest Plot of Glucose for Linemen v Non-linemen 
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